422 related articles for article (PubMed ID: 25038827)
41. SAMHD1 Functions and Human Diseases.
Coggins SA; Mahboubi B; Schinazi RF; Kim B
Viruses; 2020 Mar; 12(4):. PubMed ID: 32244340
[TBL] [Abstract][Full Text] [Related]
42. SUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cells.
Martinat C; Cormier A; Tobaly-Tapiero J; Palmic N; Casartelli N; Mahboubi B; Coggins SA; Buchrieser J; Persaud M; Diaz-Griffero F; Espert L; Bossis G; Lesage P; Schwartz O; Kim B; Margottin-Goguet F; Saïb A; Zamborlini A
Nat Commun; 2021 Jul; 12(1):4582. PubMed ID: 34321470
[TBL] [Abstract][Full Text] [Related]
43. Vpx requires active cellular dNTP biosynthesis to effectively counteract the anti-lentivirus activity of SAMHD1 in macrophages.
Bowen NE; Tao S; Cho YJ; Schinazi RF; Kim B
J Biol Chem; 2023 Aug; 299(8):104984. PubMed ID: 37390988
[TBL] [Abstract][Full Text] [Related]
44. Sulforaphane Reduces SAMHD1 Phosphorylation To Protect Macrophages from HIV-1 Infection.
Sharifi HJ; Paine DN; Fazzari VA; Tipple AF; Patterson E; de Noronha CMC
J Virol; 2022 Dec; 96(23):e0118722. PubMed ID: 36377871
[TBL] [Abstract][Full Text] [Related]
45. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates.
Lahouassa H; Daddacha W; Hofmann H; Ayinde D; Logue EC; Dragin L; Bloch N; Maudet C; Bertrand M; Gramberg T; Pancino G; Priet S; Canard B; Laguette N; Benkirane M; Transy C; Landau NR; Kim B; Margottin-Goguet F
Nat Immunol; 2012 Feb; 13(3):223-228. PubMed ID: 22327569
[TBL] [Abstract][Full Text] [Related]
46. Phosphorylation of murine SAMHD1 regulates its antiretroviral activity.
Wittmann S; Behrendt R; Eissmann K; Volkmann B; Thomas D; Ebert T; Cribier A; Benkirane M; Hornung V; Bouzas NF; Gramberg T
Retrovirology; 2015 Dec; 12():103. PubMed ID: 26667483
[TBL] [Abstract][Full Text] [Related]
47. Restricted access to myeloid cells explained.
Planelles V
Viruses; 2011 Sep; 3(9):1624-33. PubMed ID: 21994799
[TBL] [Abstract][Full Text] [Related]
48. Moderate restriction of macrophage-tropic human immunodeficiency virus type 1 by SAMHD1 in monocyte-derived macrophages.
Taya K; Nakayama EE; Shioda T
PLoS One; 2014; 9(3):e90969. PubMed ID: 24599229
[TBL] [Abstract][Full Text] [Related]
49. SAMHD1: a novel antiviral factor in intrinsic immunity.
Chen Z; Zhang L; Ying S
Future Microbiol; 2012 Sep; 7(9):1117-26. PubMed ID: 22953710
[TBL] [Abstract][Full Text] [Related]
50. SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4
Antonucci JM; Kim SH; St Gelais C; Bonifati S; Li TW; Buzovetsky O; Knecht KM; Duchon AA; Xiong Y; Musier-Forsyth K; Wu L
J Virol; 2018 Aug; 92(15):. PubMed ID: 29793958
[TBL] [Abstract][Full Text] [Related]
51. Cyclin D3-dependent control of the dNTP pool and HIV-1 replication in human macrophages.
Ruiz A; Pauls E; Badia R; Torres-Torronteras J; Riveira-Muñoz E; Clotet B; Martí R; Ballana E; Esté JA
Cell Cycle; 2015; 14(11):1657-65. PubMed ID: 25927932
[TBL] [Abstract][Full Text] [Related]
52. Mechanism of allosteric activation of SAMHD1 by dGTP.
Ji X; Wu Y; Yan J; Mehrens J; Yang H; DeLucia M; Hao C; Gronenborn AM; Skowronski J; Ahn J; Xiong Y
Nat Struct Mol Biol; 2013 Nov; 20(11):1304-9. PubMed ID: 24141705
[TBL] [Abstract][Full Text] [Related]
53. Tetramerization of SAMHD1 is required for biological activity and inhibition of HIV infection.
Yan J; Kaur S; DeLucia M; Hao C; Mehrens J; Wang C; Golczak M; Palczewski K; Gronenborn AM; Ahn J; Skowronski J
J Biol Chem; 2013 Apr; 288(15):10406-17. PubMed ID: 23426366
[TBL] [Abstract][Full Text] [Related]
54. Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells.
Bermejo M; López-Huertas MR; García-Pérez J; Climent N; Descours B; Ambrosioni J; Mateos E; Rodríguez-Mora S; Rus-Bercial L; Benkirane M; Miró JM; Plana M; Alcamí J; Coiras M
Biochem Pharmacol; 2016 Apr; 106():30-45. PubMed ID: 26851491
[TBL] [Abstract][Full Text] [Related]
55. Effects of human SAMHD1 polymorphisms on HIV-1 susceptibility.
White TE; Brandariz-Nuñez A; Valle-Casuso JC; Knowlton C; Kim B; Sawyer SL; Diaz-Griffero F
Virology; 2014 Jul; 460-461():34-44. PubMed ID: 25010268
[TBL] [Abstract][Full Text] [Related]
56. SAMHD1 restricts HIV-1 cell-to-cell transmission and limits immune detection in monocyte-derived dendritic cells.
Puigdomènech I; Casartelli N; Porrot F; Schwartz O
J Virol; 2013 Mar; 87(5):2846-56. PubMed ID: 23269793
[TBL] [Abstract][Full Text] [Related]
57. GTP is the primary activator of the anti-HIV restriction factor SAMHD1.
Amie SM; Bambara RA; Kim B
J Biol Chem; 2013 Aug; 288(35):25001-25006. PubMed ID: 23880768
[TBL] [Abstract][Full Text] [Related]
58. SAMHD1's protein expression profile in humans.
Schmidt S; Schenkova K; Adam T; Erikson E; Lehmann-Koch J; Sertel S; Verhasselt B; Fackler OT; Lasitschka F; Keppler OT
J Leukoc Biol; 2015 Jul; 98(1):5-14. PubMed ID: 25646359
[TBL] [Abstract][Full Text] [Related]
59. Allosteric Activation of SAMHD1 Protein by Deoxynucleotide Triphosphate (dNTP)-dependent Tetramerization Requires dNTP Concentrations That Are Similar to dNTP Concentrations Observed in Cycling T Cells.
Wang Z; Bhattacharya A; Villacorta J; Diaz-Griffero F; Ivanov DN
J Biol Chem; 2016 Oct; 291(41):21407-21413. PubMed ID: 27566548
[TBL] [Abstract][Full Text] [Related]
60. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.
Goldstone DC; Ennis-Adeniran V; Hedden JJ; Groom HC; Rice GI; Christodoulou E; Walker PA; Kelly G; Haire LF; Yap MW; de Carvalho LP; Stoye JP; Crow YJ; Taylor IA; Webb M
Nature; 2011 Nov; 480(7377):379-82. PubMed ID: 22056990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
